The scoreboard, and what is not on it. The hard targets, how often each is actually
looked at, and the quiet signals that never reach a dashboard.
IP Portfolio Value Growth
The year-on-year increase in the independently assessed valuation of our total IP portfolio.
Target · Achieve 10-15% annual growth in portfolio valuation. In 2024, our IP portfolio was valued at £150M. By the end of 2025, it should be £165M-£172.5M, driven by strategic filings and successful defence.
Freedom-to-Operate (FTO) Risk Reduction
The reduction in identified high-risk FTO issues for new product lines and R&D projects, measured by early-stage detection and mitigation.
Target · Reduce critical FTO risks by 20% year-on-year for projects entering Phase 2 R&D. After implementing a new early FTO review process, we identified and mitigated 3 high-risk patent conflicts in Q1 that would have otherwise caused significant delays or redesigns later on.
M&A IP Due Diligence Success Rate
The percentage of M&A deals where IP due diligence accurately identified material risks or opportunities, leading to successful integration or renegotiation.
Target · Maintain a 95%+ success rate in identifying material IP issues in M&A targets. During a £50M acquisition, your team uncovered a critical third-party patent that would have blocked a key product feature. This allowed us to renegotiate the deal terms, saving £5M.
IP Budget Efficiency
Optimisation of external IP spend (e.g., outside counsel, annuity fees, search services) relative to portfolio size and strategic objectives.
Target · Reduce IP operational costs by 10% over 3 years, whilst maintaining or increasing portfolio quality. By renegotiating terms with our top 3 external law firms and bringing certain routine tasks in-house, we reduced external spend by £1.2M in 2024 without compromising filing quality.
Strategic IP Alignment Score
A score derived from executive surveys assessing how well the IP strategy supports and enables the company's overall business and R&D objectives.
Target · Achieve an average score of 4.5/5 from C-suite and R&D leadership. Our recent survey showed that 90% of R&D leads feel the IP team is proactively identifying areas for protection that align with their project roadmaps, up from 70% last year.
Board and Executive Trust
The degree to which the Board and C-suite rely on your insights for strategic decisions, particularly those involving R&D investment, market entry, and M&A.
- Regular invitations to Board meetings for IP updates
- direct consultation by CEO/CTO on major strategic shifts
- your opinions being sought on key R&D hires or competitive responses
- proactive engagement from other executive leaders on IP matters.
Market Perception and Influence
Our standing as an IP leader in the industry, measured by our ability to influence industry standards, participate in key forums, and be recognised for our innovative IP approach.
- Invitations to speak at major industry conferences
- publications in respected IP journals
- active participation in standards bodies
- positive mentions in analyst reports regarding our IP strength
- successful licensing deals that establish market precedents.
Organisational IP Culture
The extent to which IP awareness and best practices are embedded throughout the R&D organisation, fostering a culture of innovation and protection.
- High quality and volume of invention disclosures from R&D teams
- proactive engagement from inventors in the patenting process
- R&D project leads considering IP implications early in their planning
- positive feedback from R&D staff on IP training and support programs.
Talent Development and Retention
The success in attracting, developing, and retaining top-tier IP professionals within your organisation.
- Low attrition rates within the IP team
- successful internal promotions to senior roles
- strong candidate pipeline for IP vacancies
- positive feedback in employee engagement surveys regarding career development opportunities and team culture.